Related by context. All words. (Click for frequent words.) 67 Carotid Revascularization Endarterectomy vs. 64 prospective nonrandomized 64 CHARISMA trial 63 CaPSURE 63 GEM OS1 63 EchoCRT 63 ENDEAVOR IV 63 Xelox 63 Stenting Trial CREST 63 CARE HF 63 CYPHER Stent 63 phase IIIb 62 Delcath Phase III 62 bifurcation lesions 62 Bucindolol 62 DAPT Study 62 pain palliation 62 BARI 2D 62 WallFlex Biliary RX 62 PROMUS R 62 ExTRACT TIMI 62 Tryton Medical Inc. 61 commercialize deforolimus 61 TAXUS Liberte Stent 61 VADT 61 kidney urologic 61 NAVISTAR R 61 Combo Stent 61 Urology Gynecology 61 Cholesterol Levels SPARCL 61 George Coukos 61 SYNTAX trial 61 PFO migraine 61 TRITON TIMI 61 Screening Trial DMIST 61 Val HeFT 61 Endoscopic Ablation System 61 BRIM2 61 CALGB 61 drug eluting stent DES 60 PROLARIS 60 Multicenter Automatic Defibrillator Implantation 60 carotid artery stenting 60 SYNERGY Stent 60 multicenter prospective 60 multicenter Phase III 60 EOquin TM phase 60 cediranib 60 Corus CAD 60 Bayer HealthCare Onyx Pharmaceuticals 60 Angiographic 60 BioNumerik 60 TM Everolimus Eluting 60 Myocet 60 samalizumab 60 Taxus Element 60 relapsed MM 60 DFCI 60 zotarolimus 60 TAXUS IV 60 NATRECOR ® 60 Digital Mammographic Imaging 60 HORIZONS AMI 60 thalidomide Thalomid 60 Vascugel 60 sorafenib Nexavar 60 RE LY 60 Medtronic CoreValve 60 DF HCC 60 patientswith 60 Rheos System 60 Cotavance 60 ruptured brain aneurysms 60 Microwave Ablation System 60 Pertuzumab 60 ASPIRE HIGHER 60 ZACTIMA 60 placebo controlled dose escalation 60 Inclinix 60 Kandzari 60 Dr. Ziyad Hijazi 60 TEMSO 59 Angela Christiano 59 Teriflunomide 59 multicenter randomized clinical 59 CYPHER ® Stent 59 ACRIN 59 midstage clinical 59 atypical Hemolytic Uremic Syndrome 59 olaparib 59 prospective randomized multicenter 59 INSPIRE Trial Phase III 59 oral antiplatelet agent 59 ™ Everolimus Eluting 59 stent DES 59 multicenter Phase II 59 PARTNER Trial 59 number NCT# ClinicalTrials.gov 59 Evaluation WISE 59 SPIRIT FIRST 59 novel oral anticoagulant 59 BRAF inhibitor 59 platinum chromium alloy 59 GORE TAG Device 59 bioabsorbable stent 59 TAXUS Liberte 59 Medtronic Endeavor 59 Marie Claude Morice 59 NCIC CTG 59 carotid artery stenting CAS 59 Kantarjian 59 Latuda 59 Afatinib 59 Sirolimus eluting Coronary Stent 59 Neuradiab TM 59 TAXUS Liberte Long 59 Cordis Cypher 59 ACOSOG Z# 59 multicenter placebo controlled 59 BrachySil TM 59 Sirolimus eluting 59 ABSORB trial 59 placebo controlled clinical 59 NEVO 59 CAMMS# 59 ZoMaxx 59 YONDELIS R 59 iCardiac 59 unstable angina UA 59 liver resection 59 Guillermo Torre Amione 59 EVEREST II 59 CardioFit 59 ECASS 59 MabThera rituximab 59 interventional neuroradiology 59 interferon beta therapy 59 Teplizumab 59 functional mitral regurgitation 59 HORIZONS AMI trial 59 YONDELIS 59 ToGA 59 CRLX# 59 pivotal bioequivalence 59 BR.# 59 REALITY Trial 59 BZA CE 59 TAXUS VI 58 phase IIb clinical 58 phase IIa clinical 58 pediatric neurologists 58 MAGE A3 ASCI 58 blocked carotid arteries 58 Vascugel ® 58 PROMUS Element Stent 58 LensAR 58 Orqis Medical 58 radiographic outcomes 58 PERSEUS 58 Endeavor stent 58 TAXUS Element Paclitaxel Eluting 58 undergone radical prostatectomy 58 Nicholas Borys 58 TRA 2P 58 ENDEAVOR III 58 multicenter randomized controlled 58 Everist Genomics 58 paclitaxel eluting 58 AIR2 Trial 58 Regado Biosciences 58 Zarnestra 58 Pivotal Clinical Trial 58 Evoltra ® 58 interstitial brachytherapy 58 Clinical Antipsychotic Trials 58 CHAMPION PCI 58 SYNTAX 58 CardioFocus 58 TriReme 58 PediGuard 58 Phase III placebo controlled 58 atrial fibrillation ablation 58 Wellstat 58 drug eluting coronary stents 58 PROMUS Element Everolimus Eluting 58 pertuzumab 58 SPIRIT IV 58 brivaracetam 58 reslizumab 58 Thoraxcenter Erasmus University 58 Eluting Coronary Stent System 58 HPCGG 58 zotarolimus eluting stent 58 CONQUER OB 58 AneuRx 58 Mayo Clinic Rochester MN 58 CYPHER R Stent 58 including eniluracil ADH 58 ROCKET AF 58 ALN VSP Phase 58 TQT studies 58 Trandolapril 58 double blinded randomized 58 depsipeptide 58 Pivotal Trial 58 prospective multicenter 58 multicentre study 58 Phase III multicenter 58 interventional cardiology fellowship 58 standard chemotherapy regimen 58 recurrent malignant glioma 58 LHRH receptor positive 58 Platinum Chromium 58 intracranial stenosis 58 TMS Therapy 58 gefitinib Iressa 58 XIENCE V stent 58 TAXUS TM 58 Acute Decompensated Heart Failure 58 PLX STROKE targeting 58 COR Analyzer 58 Phase III metastatic melanoma 58 Biocor 58 radiofrequency RF ablation 58 intravascular stent 58 GORE VIABAHN Endoprosthesis 58 TAXUS Express Stent 58 KYPHON Balloon Kyphoplasty 58 HealthCore 58 Spirus Medical 58 acetonide FA 58 Européenne Mark 58 JenaValve 58 CUSTOM III 58 rALLy clinical trial 58 multicenter clinical trials 58 prospective multicentre 58 placebo controlled Phase III 58 deCODE AF TM 58 AFRS TM 58 RhuDex 57 Phase IIIb study 57 metastatic malignant 57 Braunwald 57 Endurant 57 Urocortin 2 57 Celator 57 Neuroepidemiology 57 Initiates Enrollment 57 Naurex 57 Marbán 57 Edge STudy 57 RE LY trial 57 Virtual Histology 57 observational cohort study 57 Tryton Side Branch 57 Eculizumab 57 papillary renal cell carcinoma 57 STRIDE PD 57 NSABP 57 Tykerb lapatinib 57 fully bioabsorbable 57 PERSEUS clinical program 57 ENDEAVOR II 57 Aneurysm Repair 57 MADIT CRT 57 Dr. Gabriel Lasala 57 Virend Somers MD Ph.D. 57 multicenter phase 57 coronary stent merged 57 acadesine 57 sunitinib Sutent 57 Amy Abernethy 57 Subgroup analysis 57 NO# [002] 57 NexStent 57 thoracoscopic lobectomy 57 Institute DCRI 57 Angiox R 57 PROMUS 57 REMINYL ® 57 azilsartan medoxomil 57 interventional neuroradiologists 57 ROCHESTER Minn. Mayo Clinic 57 multicentre prospective 57 galiximab 57 anastrozole Arimidex 57 Caris MPI 57 NewYork-Presbyterian/Weill Cornell 57 NewYork-Presbyterian/Columbia 57 Facet Solutions 57 ONTARGET 57 Endeavor drug eluting 57 NEVO ™ 57 Bare Metal Stent 57 Endeavor DES 57 phase III ACCLAIM 57 APEX AMI trial 57 riociguat 57 Tarceva TM 57 pharmacogenomic translational research 57 mm Stent 57 Ascendra 57 randomized controlled clinical trials 57 Oncotype 57 STARFlex R 57 Intervention Effectiveness 57 thetreatment 57 ticagrelor Brilinta 57 Renal Artery 57 LEUKINE 57 PFO closure 57 ELCAP 57 neoadjuvant treatment 57 blinded randomized placebo controlled 57 SCD HeFT 57 coronary intervention 57 PREVENT IV 57 clevidipine 57 Laura Mauri 57 Biodesix 57 MD FACS FAAP 57 Cardiac Resynchronization Therapy 57 Cornea Donor Study 57 Poordad 57 Endovascular System 57 Professor Eberhard Grube 57 Amorcyte 57 novel therapeutic antibodies 57 angiographic outcomes 57 Acute Stroke 57 atherosclerosis regression 57 USGI Medical 57 Fractional Flow Reserve 57 everolimus eluting stents 57 PF # [002] 57 inhaled cyclosporine 57 NSABP C 57 TAXUS ® 57 Stent System 57 Proellex TM 57 ACUITY trial 57 SBUMC 57 TAXUS Liberte stent 57 UHCMC 57 renal denervation 57 Hepatocellular Carcinoma HCC 57 Charles Loprinzi MD 57 Mitchell Krucoff 57 evaluating mipomersen 57 fosbretabulin 57 exemestane Aromasin 57 vinca alkaloid 57 Renal Cell Carcinoma RCC 57 RESOLUTE clinical 57 Circulatory Support 57 nonsmall cell lung cancer 57 Group B CALGB 57 neratinib 57 mechanical thrombectomy 57 Raymond F. Schinazi 57 MADIT II 57 TG MV 57 Henri Mondor Hospital 57 relapsing multiple sclerosis 57 MEND CABG 57 TAXUS ATLAS 57 Mipomersen 57 nonrandomized 57 CHARM Added 57 Long Lesion 57 Liprotamase 57 Cordis Cardiology 57 #F FDG PET 57 ENESTnd 57 retrospective cohort 57 Breast conserving 57 Dr. Denise Faustman 57 prospective longitudinal 57 Dr. Victor Velculescu 57 Eugene Braunwald 57 AVOREN 57 Refractory Angina 57 oncologists surgeons 57 Dural Sealant 57 GAMMAGARD 57 ADHERE 57 Vascular Wrap TM 57 Boston Scientific Promus 57 BioTrends 57 MGd 57 Andre Terzic 57 Vitrea ® 57 Cascade LifeSciences 57 Current Author Addresses 57 coronary drug eluting 57 unresectable tumors 57 Advanced Heart Failure 57 NeuroStar TMS Therapy 56 renal artery stenting 56 Coronary Artery Bypass Graft 56 Dr. Gussak 56 Dabigatran 56 biliary stent 56 PICSO ® 56 Arch Surg 56 Stent Thrombosis 56 Medifacts 56 Acute MI 56 CYPHER ® Sirolimus eluting 56 PRIMO CABG2 56 randomized Phase IIb 56 Fablyn 56 Axxion TM 56 anti angiogenic agents 56 preclinical efficacy 56 Augment Injectable 56 Zilver PTX stent 56 clopidogrel Plavix 56 LUX Lung 56 Novasys Medical 56 DCCT EDIC 56 recurrent glioblastoma multiforme 56 FFR measurements 56 Laheru 56 Multicenter 56 paclitaxel eluting stents 56 everolimus eluting stent 56 Tyrima 56 CYPHER R Sirolimus eluting 56 Interventional cardiologists 56 HDL Selective Delipidation 56 TAXUS ARRIVE 56 Bivalirudin 56 laparoscopic bariatric surgery 56 Coronary artery calcification 56 patients undergoing percutaneous 56 thoracic aortic disease 56 Triapine 56 GVAX Pancreas Vaccine 56 paclitaxel eluting stent 56 AVERROES 56 teriflunomide 56 intra abdominal abscess 56 non resectable metastatic 56 Coherex FlatStent 56 Temsirolimus 56 Gilles Montalescot 56 carotid stenting 56 refractory metastatic 56 Gynecologic Oncology Group 56 Elena Losina 56 Cardiac Resynchronization 56 Group RTOG 56 Neuradiab 56 Apixaban 56 chronic thromboembolic pulmonary 56 endovascular therapy 56 Maxine Dunitz Neurosurgical Institute 56 Bexion 56 ximelagatran 56 reteplase 56 Lancet Oncology journal 56 EECP ® therapy 56 TIMI Study Group 56 TAXUS V 56 urethral bulking agent 56 bifurcation stent 56 Nanotechnology Characterization Laboratory 56 phase IIb study 56 Aryplase 56 sunitinib malate 56 aripiprazole Abilify 56 Intervention Effectiveness CATIE 56 Acute Myocardial Infarction 56 Ravgen 56 MD hematologist 56 Accelerated Partial Breast Irradiation 56 Tectin TM 56 myelodysplastic myeloproliferative diseases 56 phase III isavuconazole 56 StomaphyX 56 carotid artery stent 56 GERD migraine headaches 56 ICAEL 56 CorMatrix 56 Monoclonal antibody 56 PROSTVAC TM 56 Liberte TM 56 TNFerade TM 56 ILLUSTRATE 56 BR.# study 56 Endeavor Drug Eluting 56 Dr. Eberhard Grube 56 MIST II 56 Buyyounouski 56 Drug Eluting Stent System 56 CRVO 56 Acute Ischemic Stroke 56 Aalst Belgium 56 HeartNet 56 Dr. William Wijns 56 Cloretazine 56 Diabetes Interventions 56 Broncus Technologies 56 MacuSight 56 prospective observational 56 RE LY ® 56 REGENESIS Phase IIb 56 BCIRG 56 Resolute DES 56 Manja Bouman CEO 56 severe hypercholesterolemia 56 prelicensure 56 Cardiac catheterization 56 constipation OIC 56 undergoing peritoneal dialysis 56 Velcade bortezomib 56 Stent thrombosis 56 axitinib 56 GRN# 56 NT proBNP assay 56 Cedars Sinai Heart 56 t2cure GmbH 56 Intarcia 56 SORT OUT III 56 Cara Therapeutics 56 MGuard TM 56 National Emphysema Treatment 56 QTinno 56 carotid stents 56 PLCO 56 FoldRx Pharmaceuticals Inc. 56 ASTEROID 56 cilostazol 56 Eduardo Marban 56 CONBRIZA 56 Novartis Zometa 56 anticlotting drugs 56 Phase 2b kidney transplant 56 Azienda Ospedaliera 56 Transcatheter 56 Ophena 56 Immune Tolerance Network 56 Yondelis ® 56 radiolabeled TM# 56 Ixempra 56 OMAPRO ™ 56 zoledronic acid Zometa 56 regorafenib 56 HGS# 56 Pharm Olam 56 Joseph Loscalzo 56 Alexandre Abizaid 56 CUSTOM II 56 Syndax Pharmaceuticals Inc. 56 Kahalalide F 56 PSMA ADC 56 MacuCLEAR 56 TAXUS stent 56 Ozurdex 56 metastatic pancreatic 56 Dr. Roehrborn 56 Pierre Gobin 56 TASKi3 56 Muraglitazar 56 Embozene TM Microspheres 56 gadobutrol 56 landmark ATHENA 56 visceral metastases 56 NeuroFlo 56 M.D. Ph.D. 56 cortical stimulation 56 deCODE ProstateCancer TM 56 Resolute drug eluting 56 INTEGRILIN R eptifibatide Injection 56 systemic sclerosis SSc 56 Sirion Therapeutics 56 EuroIntervention 56 NCCTG N# 56 XIENCE 56 CYPHER ® 56 MD MHSc 56 atrial arrhythmias 56 Spine Wave 56 Axial Biotech 56 Fully Covered Stent 56 ReoPro 56 R Paclitaxel Eluting 56 Dynesys 56 Neoadjuvant 56 MitraClip device 56 SUTENT ® 56 Cardiocore 55 CEDRA 55 Abbott bioabsorbable everolimus eluting 55 Screening Trial 55 biliary tract cancer 55 Sipuleucel T 55 refractory angina 55 Optical Coherence Tomography 55 EOS NASDAQ MELA 55 stereotactic radiotherapy 55 DuraHeart LVAS 55 farletuzumab 55 BridgePoint Medical 55 Intervention Trial GAIT 55 Dr. Fehlings 55 statin Crestor 55 vProtect TM Luminal Shield 55 ACCULINK 55 Interventional Cardiologists 55 Renata Pasqualini 55 Phase IIb III 55 Anti Bacterial Envelope 55 randomized multicenter 55 Neuronetics 55 Amarenco 55 Gregory D. Casciaro 55 Endoscopic ultrasound 55 SilverHawk Plaque Excision System 55 Phase 1b clinical trials 55 Edwards SAPIEN valve 55 Edwards SAPIEN transcatheter aortic 55 IMiDs ® compound 55 cardio renal 55 carotid stent 55 Intravitreal 55 Stabilimax 55 gastrointestinal malignancies 55 GRNVAC1 55 chronic myocardial ischemia 55 NewYork-Presbyterian/Weill Cornell Medical 55 tramiprosate Alzhemed TM 55 cinacalcet 55 Acute Myocardial Infarction AMI 55 everolimus eluting 55 metastatic lung cancer 55 metaglidasen 55 Cimzia certolizumab pegol 55 figitumumab 55 Endovascular Valve Edge 55 transesophageal echocardiography 55 recurrent GBM 55 Polyzene R F 55 Registry NOPR 55 Tibotec BVBA 55 Sulpizio Family 55 ARCOXIA 55 Aplidin 55 Neurodegenerative Disorders 55 Valiant Thoracic Stent Graft 55 LibiGel Phase III 55 Cardiovascular Magnetic Resonance 55 RF ablation 55 NovoCure 55 NCCTG 55 x ray angiography 55 EnteroMedics proprietary neuroblocking technology 55 enzastaurin 55 rosuvastatin Crestor 55 fluvastatin 55 hemodialysis patients 55 Abbott Xience V 55 nondiabetic patients 55 SIX RO ROG 55 Amgen denosumab 55 preclinical pharmacology 55 Getzenberg 55 portal vein thrombosis 55 Aprotinin 55 TM Embolic Protection 55 TAXUS Express2 55 gynecologic procedures 55 somatostatin analog 55 evaluating Nexavar 55 APEX PD 55 cardiac resynchronisation therapy 55 direct thrombin inhibitors 55 Demonstrates Sustained 55 ProLindac TM 55 TargetScan 55 BEXXAR Therapeutic Regimen 55 BioSTAR TM 55 PROTEGE 55 Revlimid lenalidomide 55 Wadih Arap 55 directed thrombolysis 55 Oxiplex 55 Gynecologic 55 RRMS patients 55 Cardiovascular Intervention 55 CIMZIA TM certolizumab pegol 55 vaginally administered lidocaine 55 prospective observational studies 55 HCV SPRINT 55 NSABP B 55 Shoelson 55 DMIST 55 HuMax EGFr 55 thorough QT 55 lung esophageal 55 bioabsorbable drug eluting 55 Cribier 55 LipiScan 55 BioRexis 55 Charis Eng 55 patients undergoing CABG 55 invasive candidiasis 55 Electrophysiology Lab 55 Pervasis 55 Hospitals Leuven Belgium 55 non valvular atrial 55 Clinical Therapeutics 55 Omacetaxine 55 VTE prevention 55 interventional neuroradiologist 55 Custom NX 55 thoracic aortic aneurysms 55 CardioPass 55 receiving SIMPONI 55 ONCONASE R 55 aortic stent grafts 55 Campath alemtuzumab 55 PROMUS TM 55 Doxil ® 55 prospective multicenter randomized 55 Powerlink System 55 superficial bladder cancer 55 eluting stent 55 transurethral 55 TAXUS Stent 55 INTEGRILIN 55 vorinostat 55 prospective multicenter study 55 Cardiac Dimensions 55 EQUIP OB 55 Tom Misteli 55 confirmatory clinical 55 EyeGate 55 juvenile idiopathic arthritis 55 ENDEAVOR 55 TTF Therapy 55 Ellex 2RT 55 Thoracic Oncology 55 Lodotra TM 55 Diasome 55 venous thromboembolic disease 55 Scaffold Based 55 Zilver PTX 55 Panacea Pharmaceuticals Inc. 55 acute humoral rejection 55 ENDEAVOR clinical 55 CTO recanalization 55 torcetrapib atorvastatin 55 Functional Neurosurgery 55 humanized therapeutic 55 Pemetrexed 55 QualityMetric 55 Element Stent 55 Paclitaxel eluting 55 electrophysiology EP 55 EOquin TM 55 cardiac resynchronization 55 Werner Hacke 55 Proxinium TM 55 Enobia 55 multivessel disease 55 superDimension 55 interventional therapies 55 Eluting Stent 55 OLYMPIA registry 55 Pfizer Sutent 55 PROMUS ® 55 EURIDIS 55 Inegy 55 MADIT CRT trial 55 Transcatheter aortic valve implantation 55 Surgical resection 55 multicentre randomized 55 ongoing Phase IIIb 55 AIR CF2 55 CIPN 55 clazosentan 55 Sc.M. 55 Heart Transplant Recipients 55 unresectable liver cancer 55 LUMINATE 55 pancreatic adenocarcinoma 55 evaluating T DM1 55 CLARITY study 55 arteriovenous malformations 55 Observational Study 55 carotid surgery 55 Trophos 55 Elan NanoCrystal 55 SWOG 55 mTOR inhibitor 55 Cypher Sirolimus 55 deforolimus 55 Cardioxyl Pharmaceuticals 55 haematological cancers 55 balloon kyphoplasty procedure 55 Paradigm Spine 55 randomized Phase III 55 QNEXA ® 55 GGF2 55 APPRAISE 55 coexisting illnesses 55 photodynamic treatment 55 immunotherapeutic vaccine 55 StemEx R 55 Cedars Sinai Maxine Dunitz 55 ATS Simulus R 55 vildagliptin 55 HNRCA 55 Lumbar Interbody Fusion 55 Edmundowicz 55 Cordis Cypher stent 55 CROSSER 55 oral antiplatelet therapy 55 lung liver pancreas 55 RAPAFLO TM 55 Limperopoulos 55 Novartis Molecular Diagnostics 55 carotid endarterectomy CEA 55 Chicago Multidisciplinary Symposium 55 acute coronary syndromes ACS 55 Bonati Institute 55 rt PA 55 CYPHER R Sirolimus Eluting 55 myoblast therapy 55 Randomized Evaluation 55 Dr. Grekos 55 Zemplar Capsules 55 NEVO RES 55 Tsimikas 55 osteoporotic compression fractures 55 EASE Trial 55 NovaVision VRT 55 Etanercept 55 ASCEND HF 55 Coronary Stent 55 OncoVEX 55 Everolimus Eluting Coronary Stent 55 Cardiovascular Imaging 55 Judith Hochman 55 Certolizumab pegol 55 IlluminOss 55 PressureWire Certus 54 OZURDEX 54 postmarketing adverse 54 Sapien valve 54 Inc. OTCBB CYKN 54 CIMZIA ™ 54 painful vertebral compression 54 ERBE GmbH 54 Genous 54 KYTHERA 54 Phase Ib II 54 OHSU Doernbecher 54 Iruela Arispe 54 Patrick Serruys 54 QuadraSphere 54 TYRX 54 colorectal liver metastases 54 computed tomography angiography 54 levosimendan 54 anti arrhythmic drug 54 Prospective Randomized 54 trodusquemine 54 Kallmes 54 CYPHER stent 54 Angiox ® 54 Adenosine Therapeutics 54 assessing T DM1 54 descending thoracic 54 BLP# Liposome Vaccine 54 BIIR 54 Cardiac Stem Cell 54 CVCTA Education 54 TriActiv R 54 MGuard ™ 54 anastrazole 54 narrow QRS 54 bioabsorbable polymer 54 IL# PE#QQR 54 CALGB # [002] 54 ACCORD Eye 54 BRIM3 54 PRESEPT study 54 PDE# inhibitors 54 lapatinib Tykerb 54 Phase Ib IIa clinical 54 phase IIa 54 ADMIRE HF 54 TAXUS Liberté 54 Ronald DePinho 54 ThermoDox R 54 Sequenom SEQureDx Technology 54 Women Ischemia Syndrome 54 thoracic surgeons 54 Electrophysiologist 54 Current Controlled Trials 54 thoracic surgical 54 Hematological 54 Histopathology 54 metastatic gastric 54 Oncologic 54 Addrenex Pharmaceuticals 54 elective PCI 54 Resolute stent 54 PressureWire 54 transesophageal echocardiography TEE 54 vascular anatomy 54 neuroradiologists 54 TAXUS Element 54 Stereotactic Body Radiation Therapy 54 REVIVE Diabetes 54 bronchial thermoplasty 54 Dr. Ihor Gussak 54 Outcome Sciences 54 Viatronix 54 Onrigin 54 genitourinary cancers 54 NovoStent 54 stroke hypertension palpitations 54 UMC Utrecht 54 Aggressive Reduction 54 percutaneous coronary interventions 54 INFUSE Bone Graft 54 gastroenterological 54 Zevalin consolidation 54 SYNTAX Score 54 coronary stenting 54 TAXUS 54 MammoSite RTS 54 Sideguard 54 Monica Mita 54 Bruce Psaty 54 recurrent glioma 54 Deutsches Herzzentrum 54 BRAF mutated 54 Sudhir Agrawal D.Phil 54 Neurotherapeutics 54 Meta analyzes 54 Catena ® 54 Bradley Boeve 54 DermTech International 54 Tissue Matrix 54 DU #b 54 Musculoskeletal Diseases 54 Acute myocardial infarction 54 Express LD Iliac 54 FSCAI 54 Bairey Merz 54 Genous stent 54 pamidronate 54 CardioVascular 54 DAPT 54 Systemic Sclerosis 54 Simulect 54 BASEL AFX Novartis AG 54 budesonide MMX Phase III 54 TORS 54 Refractec 54 Spectranetics laser 54 carisbamate 54 randomized Phase 2b 54 Spine Patient Outcomes 54 QOPI 54 MitraClip R 54 XIENCE V drug eluting 54 Unstable Angina 54 Decision Biomarkers 54 subcutaneous immunoglobulin 54 BrainGate Neural Interface 54 deferiprone 54 Nuon Therapeutics 54 Convergent Procedure 54 Demark Wahnefried 54 essential thrombocythemia ET 54 Amrubicin 54 Thoracic Endoprosthesis 54 PHX# 54 genomewide association study 54 multicenter clinical 54 invasive lobular carcinoma 54 Prof. Gozes 54 Cellular Therapies 54 anastomotic devices 54 Dr. Nabil Dib 54 Catheterization Lab 54 Proxinium 54 Hematopathology 54 placebo controlled Phase 54 Herman Scholtz 54 OvaRex MAb 54 Zivadinov